Our Sponsors

  • Hot Stocks to Watch Today | ALTI | MBRK | IHSN | SPIR | OSIR |

    Akorn
    Wednesday May 5th, 2010 at 08:58 am EST

    Hot Stocks for Wednesday 05/05/2010  ALTI, MBRK, SPIR, OSIR, 

    Hey Friends,

    Hot stocks to watch on Wednesday 05/05/2010  are
    ALTI - Altair Nanotechnologies Inc.
    MBRK - MiddleBrook Pharmaceuticals Inc.
    SPIR - Spire Corporation
    OSIR - Osiris Therapeutics Inc.
     
    ALTI - The latest news informs about an order worth $850,000. Its not a huge order which can drag this stock more. But it creates a hype in the market which along with paid publicity can do great things. Overall not much impressive but deserves a place in hot list for day trade.
    News
    Altair Nanotechnologies Receives New $850,000 Purchase Order From Proterra Inc.
    Altair Nanotechnologies, Inc., a leading provider of energy storage systems for clean, efficient power and energy management, today announced the receipt of a follow-on $850,000 purchase order for its advanced lithium-ion battery modules required by Proterra to satisfy immediate end customer requirements for new all electric and hybrid electric transit buses. This purchase is a follow-on order from the initial $898,400 contract announced in August 2009.
    Source : MarketWatch

    MBRK- Hot Stock?? MBRK!!!  They filed for Chapter 11 Bankruptcy protection. Such stocks usually have a huge jump after few days on filing. Many companies like Circuit city, WAMUQ, LEHMQ did the same thing. I want you to keep this in watch list. This can double your money in no time. On a slightest positive hint, you should dare to trade this kid. Invest Wisely, its your own Money. 
    News
    MiddleBrook Pharmaceuticals Seeks Chapter 11
    Drug maker MiddleBrook Pharmaceuticals Inc. said it filed for Chapter 11 bankruptcy protection. According to court documents, the company listed assets of $42.2m and liabilities of $29.1m as of 31 December 2009.
    Source : Financier 

    SPIR - Positive news. Company secures U.S. GSA Contract. 20-30% gain expected.
    News
    Spire Corporation Secures U.S. GSA Contract
    Spire Corporation announced that it has been awarded a United States General Services Administration (GSA) contract and is now listed on GSA`s Schedule 56, under Special Identification Number (SIN) 206-3, as a Small Business entity. The GSA Schedule 56 is a contract listing prices the Government has agreed to pay for Spire Solar Systems` products and services, an approach to purchasing which is favored by most federal buyers.
    Source : Reuters

    OSIR - Their Stem cell Therapy treatment for Type 1 Diabetes got Orphan Drug designation by the FDA. Orphan Drug designation provides market exclusivity for up to seven years following approval, eliminates FDA filing and registration fees, and provides tax incentives for as much as 50 percent of the clinical development costs. This will gain heavily on this news and on further development news in the future.
    News
    Osiris Therapeutics Receives FDA Orphan Drug Designation for Stem Cell Treatment for Type 1 Diabetes
    Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States
    Source : BusinessWire


    Work smart Today to enjoy your Tomorrow.

    God Bless,
    Be Rich.

     

0 comments:

Leave a Reply

Latest Posts